cro.directory
← Home
Crux Biolabs logo

Crux Biolabs

Australian bioanalysis. Direct scientific expertise. Global clinical impact.

Australia-based bioanalytical CRO offering small molecule LC-MS PK, ligand-binding large molecule PK, immunogenicity (ADA), biomarker, and flow cytometry assays for clinical programs. Services are delivered within an ISO/IEC 17025-accredited scope where applicable. Headquartered in Bayswater, Australia.

Indications / Therapeutic Areas

Services

Modalities

About this organization

Bioanalytical services for clinical development

Crux Biolabs provides bioanalytical services for clinical programs across therapeutic areas, including vaccines, infectious diseases, oncology, metabolic diseases, and inflammatory and autoimmune diseases.

Service lines

  • Pharmacokinetics (PK): small molecule PK (LC-MS), large molecule PK (ligand-binding assays), and cell therapy PK (flow cytometry).
  • Pharmacodynamics (PD): immunogenicity (anti-drug antibody) testing, biomarker analysis (including Luminex), flow cytometry, and cellular immunology and functional assays.
  • Laboratory services: PBMC isolation and sample storage.

Differentiators

  • Australian-based scientific support with direct access to experienced scientists who tailor bioanalytical strategies to study requirements.
  • Services delivered within an ISO/IEC 17025-accredited scope, where applicable, and NATA accredited services.
  • Harmonised spectral flow cytometry support across participating laboratories in Australia, the United States and Europe.

Locations

  • Bayswater

    Bayswater · Victoria · Australia

Similar profiles by shared services, phases, and indications.

View all alternatives →See similar CROs ranked by shared capabilities

Submit a verified review for this organization.

Markdown mirror: /companies/cruxbiolabs.md